Identification of miR-30d as a novel prognostic maker of prostate cancer

Prostate cancer (PCa) is the most common malignant carcinoma that develops in men in Western countries. MicroRNA (miRNA) have the potential to be used as biomarkers and therapeutic targets for the treatment of various cancers. We found significantly higher expression of miR-30d in 3 PCa cell lines (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Naohito, Uemura, Hiroji, Nagahama, Kiyotaka, Okudela, Koji, Furuya, Mitsuko, Ino, Yoko, Ito, Yusuke, Hirano, Hisashi, Inayama, Yoshiaki, Aoki, Ichiro, Nagashima, Yoji, Kubota, Yoshinobu, Ishiguro, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717805/
https://www.ncbi.nlm.nih.gov/pubmed/23231923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717805/
https://www.ncbi.nlm.nih.gov/pubmed/23231923

Ejemplares similares